External ventricular drainage (EVD), also known as ventriculostomy or extraventricular drain, is a medical procedure performed in neurosurgical intensive care unit. Ventriculostomy is performed to remove excess cerebrospinal fluid to measure and maintain intracranial pressure using ventricular drainage set. Ventricular drainage set is used in medical conditions such as severe closed head injury, intracranial hypertension, intraventricular or subarachnoid hemorrhages, transient occlusive hydrocephalus, and inflammatory diseases of the cerebrospinal space. Ventricular drainage set comprises catheter, drainage bag, and monitor. Increasing prevalence of medical condition, which demands use of ventricular drainage sets is expected to be a key factor driving growth of the ventricular drainage sets market over the forecast period.

High incidence of intraventricular hemorrhage associated with premature baby birth is expected to drive the ventricular drainage sets market growth over the forecast period. According to study published in Child’s Nervous System, 2016, intraventricular hemorrhage is commonly observed in 15%-20% of babies born before 32 weeks of gestation.

Furthermore, rising incidence of neurological disorders is leading to increasing demand for ventricular drainage sets, in turn propelling the ventricular drainage sets market growth. According to American Neurological Association, 2017, annual incidence of traumatic brain injury in the U.S. ranges from 1.4 million to 1.7 million. Moreover, the rate of traumatic injury increases with increasing age due to weakened neurological response.

Increasing road accidents is also expected to propel growth of the ventricular drainage set market. In countries such as India and China, road accidents accounts for high rate of traumatic injuries, in turn leading to increasing demand for ventricular drainage sets. For instance, according to Government of India, in 2016, injuries, disabilities, and deaths caused by road accidents accounted for around 494,624 injuries, with 1,317 accidents per day.

New product approvals are further contributing towards the ventricular drainage sets market growth. For instance, in 2017, Arkis BioScience, an innovator and provider of minimally invasive surgical instrumentation and catheters for surgeries, received FDA clearance for its product, CerebroFlo, a new external ventricular catheter.

Ventricular Drainage Sets Market – Regional Analysis

The global ventricular drainage sets market is segmented in North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America ventricular drainage sets market is expected to hold dominant position in the market. This is owing to increasing demand from rising hospitalizations associated with traumatic brain injury. For instance, according to Morbidity and Mortality Weekly Report (MMWR) Surveillance Summaries 2017, the rate of traumatic brain injury related emergency department visits in the U.S. increased by 47% whereas death rates decreased by 5%, over the duration of six years (2007–2013). The decrease in death rate is expected to be due to increasing adoption of medical equipment to better serve the patients.